macular degeneration
Macular Degeneration
... The macula is an area at the back of your eye that you use for seeing fine detail such as reading a book. Macular degeneration (MD) covers a number of conditions which affect the macula. The conditions ...
12
Age-related macular degeneration: experimental and emerging treatments
... Therefore, this imaging modality may be useful for monitoring experimental treatments intended to slow down or halt atrophic AMD. The current literature, however, consists only of non- randomized cases series. This was ...
8
Anxiety and depression in patients with advanced macular degeneration: current perspectives
... Age-related macular degeneration (AMD) – despite advances in prevention and medical treatment options – remains prevalent among older adults, often resulting in functional losses that negatively affect the ...
9
Genetics and age-related macular degeneration: a practical review for the clinician
... Age-related macular degeneration (AMD), in both neovascular and non-neovascular forms, is a leading cause of irreversible visual loss throughout the developed ...
7
Retinal and choroidal thickness in early age-related macular degeneration
... FIGURE 3: Retinal thickness in early age related macular degeneration (AMD) along the vertical meridian. Retinal thickness for normal (black squares) and early AMD (open circles) participants from 2mm ...
16
Overstaying their welcome: defective CX3CR1 microglia eyed in macular degeneration
... Age-related macular degeneration (AMD), the most common cause of blind- ness in the elderly, is characterized by degeneration of the macula and can lead to loss of fine color ...
6
Conbercept for patients with age-related macular degeneration: a systematic review
... Age-related macular degeneration (AMD) is a progressive chronic disease of the central retina (the macula) and will result primarily in loss of central ...
12
Early detection of age related macular degeneration: current status
... Early diagnosis and treatment of choroidal neovascularization (CNV), a main cause of severe vision loss in age related macular degeneration (AMD), is crucial in order to preserve vision[r] ...
8
Radiation therapy for neovascular age-related macular degeneration
... Abstract: Antivascular endothelial growth factor (anti-VEGF) therapies represent the standard of care for most patients presenting with neovascular (wet) age-related macular degeneration (neovascular AMD). ...
7
Recent developments in the management of dry age-related macular degeneration
... Age-related macular degeneration (AMD) is a complex and widespread disease that represents a public health problem and a significant challenge for current economic ...
12
Risks of age related macular degeneration and led lighting
... age-related macular degeneration evolves and on a part which eye age pigment plays in the ...age-related macular degeneration will grow drastically; it will eventually lead to an increased ...
18
Recent developments in age-related macular degeneration: a review
... age-related macular degeneration (AMD), diagnostic tools, and therapeutic modalities presently available or underway for both atrophic and wet forms of the ...
18
Recent developments in the treatment of age related macular degeneration
... Age-related macular degeneration (AMD) is the leading cause of irreversible blindness in industrialized countries (1). Recent advances in retinal imaging technology, including noninvasive, high-resolution ...
10
Microcurrent stimulation in the treatment of dry and wet macular degeneration
... closed lid has been used. A study by Shinoda et al in 2008 applied this approach to 16 patients with wet age-related macular degeneration (WAMD) and to five with dry age- related macular ...
9
Targeted therapy in age-related macular degeneration (AMD)
... Age-related macular degeneration (AMD) is a major cause of vision loss in developed countries, especially in the geriatric population. The incidence of blindness as a consequence of this condition is 8.7%. ...
7
The Relation Between Age Related Macular Degeneration and Thyroid Disorders
... [10] Douglas IJ, Cook C, Chakravarthy U, et al. A case-control study of drug risk factors for age-related macular degeneration. Ophthalmology. 2007; 114: 1164–1169. [11] Bromfield S, Keenan J, Jolly P, ...
5
Profile of conbercept in the treatment of neovascular age-related macular degeneration
... Abstract: In developed countries, age-related macular degeneration (AMD) is the leading cause of irreversible blindness in individuals over the age of 65 years. Vascular endothelial growth factor (VEGF) ...
10
Full-thickness macular hole formation following anti-VEGF injections for neovascular age-related macular degeneration
... Purpose: Macular hole (MH) is part of a group of age-related degenerative diseases characterized by pathology of vitreomacular ...age-related macular degeneration (nAMD) affects older patients and is ...
5
Age-related macular degeneration: a target for nanotechnology derived medicines
... animals, RPE transplantation in human has failed so far to provide effective treatments. In a recent study, magnetite nanoparticles were used to construct and deliver RPE cell sheets in vitro (Ito et al 2005). The ...
14
Treatment of neovascular age-related macular degeneration: Current therapies
... Age-Related Macular Degeneration, or MARINA) was a two-year, phase III trial designed to evaluate monthly injections in 716 patients with mini- mally classic or occult with no classic ...
8